Platform Features
Platform Features
Features
Investment Products
Private Wealth Management
Trading Tools
Market Data Services
Analysis Tools
News Services
For Developers
Account Types
For Individuals
For Institutions
Café
More
Log in / Sign up
© 2026 Longbridge｜
Terms of Service
Privacy Policy
Disclaimer
Braveheart Bio
BRVE
27.420
5.35% ( -1.550 )
Closed: Aug 20, 16:00:00 (EDT)
Start trading
Overview
Overview
Options
Options
News
News
Posts
Posts
Financials
Financials
Forecast
Forecast
Valuation
Valuation
Shareholders
Shareholders
Profile
Profile
All Shareholders
Institutional Holders
Insiders
All Shareholders
Shareholder Type
VC/PE firms
34.61%
Public and others
34.36%
Individuals & Insiders
19.26%
Public companies
11.77%
Major Shareholders
Major Shareholders Latest
Shareholder
% Held
Shares Held
Change %
Shares Changed
Report Date
Forbion Capital Partners B.V.
34.01%
21.83M
--
+21.83M
08/07/2026
OrbiMed Advisors LLC
18.55%
11.90M
--
+11.90M
08/07/2026
Andreessen Horowitz LLC
15.95%
10.23M
--
+10.23M
08/07/2026
Travis Murdoch
CEO, President & Director
12.99%
8.33M
--
+8.33M
08/07/2026
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
11.56%
7.42M
--
+7.42M
08/07/2026
Jason Coloma
Former Director
1.71%
1.10M
--
+1.10M
08/05/2026
David Malek
Director
1.58%
1.01M
--
+1.01M
08/07/2026
James Rickey
Chief Financial Officer
1.10%
703.58K
--
+703.58K
08/07/2026
Christopher Viehbacher
Independent Chairman
0.95%
609.52K
--
+609.52K
08/07/2026
Michele Anderson
Chief Development Officer
0.52%
332.16K
--
+332.16K
08/07/2026
David Lubner
Independent Director
0.09%
55.56K
--
+55.56K
08/07/2026
